Transcriptional and epigenetic networks in the development and maturation of dendritic cells.

Dendritic cells (DCs) are professional antigen-presenting cells that provide a critical link between the innate and adaptive immune responses. The genetic program required for differentiation of DCs from their hematopoietic precursors is controlled by both cytokines and transcription factors. The signals transduced from cytokines recruit specific transcription factors, enabling the expression of a distinct transcriptome that is required for specification of different DC lineages. The establishment of a distinct transcriptome also depends on chromatin modifications associated with critical cis elements of lineage-specific genes. In this review, recent advances in the understanding of the transcriptional network governing DC lineage specification are summarized, along with current views of the dynamic DC epigenome.

[1]  Nir Friedman,et al.  A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. , 2012, Molecular cell.

[2]  M. Mohty,et al.  Impact of valproic acid on dendritic cells function. , 2012, Immunobiology.

[3]  Ansuman T. Satpathy,et al.  Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages , 2012, The Journal of experimental medicine.

[4]  M. Nussenzweig,et al.  Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage , 2012, The Journal of experimental medicine.

[5]  S. Saccani,et al.  Cell-type-specific control of enhancer activity by H3K9 trimethylation. , 2012, Molecular cell.

[6]  Scott B. Dewell,et al.  Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response , 2012, The Journal of experimental medicine.

[7]  R. Steinman.  Decisions about dendritic cells: past, present, and future. , 2012, Annual review of immunology.

[8]  J. O’Shea,et al.  Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. , 2012, Annual review of immunology.

[9]  R. Qi,et al.  Histone deacetylase activity is required for skin Langerhans cell maturation and phagocytosis. , 2012, Journal of dermatological science.

[10]  R. Yang,et al.  Global mapping of H3K4me3 and H3K27me3 reveals chromatin state-based regulation of human monocyte-derived dendritic cells in different environments , 2012, Genes and Immunity.

[11]  Jianxun Song,et al.  Global Mapping of H3K4me1 and H3K4me3 Reveals the Chromatin State-Based Cell Type-Specific Gene Regulation in Human Treg Cells , 2011, PloS one.

[12]  M. Mohty,et al.  Impact of the hypomethylating agent 5-azacytidine on dendritic cells function. , 2011, Experimental hematology.

[13]  Gernot Posselt,et al.  Suppressor of Cytokine Signaling 2 Is a Feedback Inhibitor of TLR-Induced Activation in Human Monocyte-Derived Dendritic Cells , 2011, The Journal of Immunology.

[14]  G. Trinchieri,et al.  Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? , 2011, Nature Reviews Immunology.

[15]  Robert S. Illingworth,et al.  Cell type-specific DNA methylation at intragenic CpG islands in the immune system. , 2011, Genome research.

[16]  A. Fisher,et al.  Chromatin states in pluripotent, differentiated, and reprogrammed cells. , 2011, Current opinion in genetics & development.

[17]  D. Hume,et al.  Applications of myeloid‐specific promoters in transgenic mice support in vivo imaging and functional genomics but do not support the concept of distinct macrophage and dendritic cell lineages or roles in immunity , 2011, Journal of leukocyte biology.

[18]  B. Reizis,et al.  Plasmacytoid dendritic cells: recent progress and open questions. , 2011, Annual review of immunology.

[19]  L. Kobzik,et al.  Allergy risk is mediated by dendritic cells with congenital epigenetic changes. , 2011, American journal of respiratory cell and molecular biology.

[20]  D. Venzon,et al.  TLR3-Specific Double-Stranded RNA Oligonucleotide Adjuvants Induce Dendritic Cell Cross-Presentation, CTL Responses, and Antiviral Protection , 2011, The Journal of Immunology.

[21]  K. Anderson,et al.  HDAC Inhibition by LBH589 Affects Phenotype and Function of Human Myeloid Dendritic Cells , 2010, Leukemia.

[22]  R. Kolde,et al.  Genome-wide promoter analysis of histone modifications in human monocyte-derived antigen presenting cells , 2010, BMC Genomics.

[23]  R. Steinman,et al.  Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas , 2010, Cell.

[24]  M. Nussenzweig,et al.  Route of Antigen Uptake Differentially Impacts Presentation by Dendritic Cells and Activated Monocytes , 2010, The Journal of Immunology.

[25]  Robert S. Illingworth,et al.  Orphan CpG Islands Identify Numerous Conserved Promoters in the Mammalian Genome , 2010, PLoS genetics.

[26]  H. Nechushtan,et al.  The enigma of the role of protein inhibitor of activated STAT3 (PIAS3) in the immune response. , 2010, Trends in immunology.

[27]  B. Reizis.  Regulation of plasmacytoid dendritic cell development. , 2010, Current opinion in immunology.

[28]  M. Nussenzweig,et al.  Origin and development of dendritic cells , 2010, Immunological reviews.

[29]  F. Ginhoux,et al.  Origin and functional heterogeneity of non‐lymphoid tissue dendritic cells in mice , 2010, Immunological reviews.

[30]  Markus G. Manz,et al.  Development of Monocytes, Macrophages, and Dendritic Cells , 2010, Science.

[31]  K. Stuhlmeier,et al.  Epigenetic regulation of dendritic cell differentiation and function by oxidized phospholipids. , 2009, Blood.

[32]  W. Heath,et al.  Dendritic cell subsets in primary and secondary T cell responses at body surfaces , 2009, Nature Immunology.

[33]  Andreas Hutloff,et al.  Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells. , 2009, Immunity.

[34]  Zachary D. Smith,et al.  Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses , 2009 .

[35]  F. Ginhoux,et al.  Origin of the lamina propria dendritic cell network. , 2009, Immunity.

[36]  Serita M. Nelesen,et al.  Rapid and Accurate Large-Scale Coestimation of Sequence Alignments and Phylogenetic Trees , 2009, Science.

[37]  A. Brooks,et al.  Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells , 2009, Nature Immunology.

[38]  A. Rudensky,et al.  In Vivo Analysis of Dendritic Cell Development and Homeostasis , 2009, Science.

[39]  S. Chun,et al.  Apicidin, the Histone Deacetylase Inhibitor, Suppresses TH1 Polarization of Murine Bone Marrow-Derived Dendritic Cells , 2009, International journal of immunopathology and pharmacology.

[40]  F. Geissmann,et al.  Blood monocytes: development, heterogeneity, and relationship with dendritic cells. , 2009, Annual review of immunology.

[41]  C. Dinarello,et al.  Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. , 2008, The Journal of clinical investigation.

[42]  Y. Dou,et al.  Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response. , 2008, Blood.

[43]  Clare L. Bennett,et al.  DC ablation in mice: promises, pitfalls, and challenges. , 2007, Trends in immunology.

[44]  K. Schroder,et al.  Histone deacetylase inhibitors decrease Toll‐like receptor‐mediated activation of proinflammatory gene expression by impairing transcription factor recruitment , 2007, Immunology.

[45]  Melanie Bahlo,et al.  Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo , 2007, Nature Immunology.

[46]  D. Jarrossay,et al.  Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow , 2007, Nature Immunology.

[47]  J. Bluestone,et al.  Loss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in mice , 2007 .

[48]  A. Thomson,et al.  Tolerogenic dendritic cells and the quest for transplant tolerance , 2007, Nature Reviews Immunology.

[49]  A. Ballestrero,et al.  Histone Deacetylase Inhibitors Affect Dendritic Cell Differentiation and Immunogenicity , 2007, Clinical Cancer Research.

[50]  G. Freeman,et al.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection , 2007, Nature Immunology.

[51]  S. Szabo,et al.  Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function. , 2007, Blood.

[52]  R. Steinman,et al.  Differential Antigen Processing by Dendritic Cell Subsets in Vivo , 2007, Science.

[53]  R. Schreiber,et al.  Bone Marrow Stromal Cell Antigen 2 Is a Specific Marker of Type I IFN-Producing Cells in the Naive Mouse, but a Promiscuous Cell Surface Antigen following IFN Stimulation1 , 2006, The Journal of Immunology.

[54]  Li Wu,et al.  Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes , 2006, Nature Immunology.

[55]  Vincenzo Cerundolo,et al.  Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. , 2006, Blood.

[56]  H. Sandoval,et al.  Dendritic Cell Apoptosis in the Maintenance of Immune Tolerance , 2006, Science.

[57]  Ana Cumano,et al.  A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells , 2006, Science.

[58]  R. Zinkernagel,et al.  Histological analysis of CD11c‐DTR/GFP mice after in vivo depletion of dendritic cells , 2005, Clinical and experimental immunology.

[59]  Melody A. Swartz,et al.  Dendritic-cell trafficking to lymph nodes through lymphatic vessels , 2005, Nature Reviews Immunology.

[60]  M. Willart,et al.  In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma , 2005, The Journal of experimental medicine.

[61]  T. Blankenstein,et al.  CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. , 2004, Immunity.

[62]  G. Belz,et al.  Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[63]  C. Dinarello,et al.  Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[64]  A. D'amico,et al.  The Early Progenitors of Mouse Dendritic Cells and Plasmacytoid Predendritic Cells Are within the Bone Marrow Hemopoietic Precursors Expressing Flt3 , 2003, The Journal of experimental medicine.

[65]  Yong‐jun Liu,et al.  Mouse and human dendritic cell subtypes , 2002, Nature Reviews Immunology.

[66]  G. Fantuzzi,et al.  The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Antonio Lanzavecchia,et al.  BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction , 2001, The Journal of experimental medicine.

[68]  W. Heath,et al.  Cutting Edge: Intravenous Soluble Antigen Is Presented to CD4 T Cells by CD8− Dendritic Cells, but Cross-Presented to CD8 T Cells by CD8+ Dendritic Cells1 , 2001, The Journal of Immunology.

[69]  M. Bevan,et al.  Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo , 2000, The Journal of experimental medicine.

[70]  J. Banchereau,et al.  The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand , 1997, The Journal of experimental medicine.

[71]  N. Copeland,et al.  Identification of soluble and membrane-bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs. , 1995, Oncogene.

[72]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[73]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[74]  D. Harrison,et al.  Faculty of 1000 evaluation for Deciphering the transcriptional network of the dendritic cell lineage. , 2012 .

[75]  R. Steinman,et al.  Pillars Article: Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med.1973. 137: 1142-1162. , 2007, Journal of immunology.

[76]  J. Bluestone,et al.  Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. , 2007, Nature.

[77]  K. Minas,et al.  Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal? , 2006, Critical reviews in immunology.

[78]  Ira Mellman,et al.  Cell biology of antigen processing in vitro and in vivo. , 2005, Annual review of immunology.